| (PLN) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 61.87M | — |
| Operating expense | — | — |
| Net income | 162.60M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLN.WA returned -3.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +9.1% |
| 1 year | -3.5% |
| 5 years | -46.8% |
| All-time high | zł 49.40 (Mar 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what zł1,000 in CLN.WA would be worth today ›No. Celon Pharma S.A. has not paid a dividend in the past 12 months.
Celon Pharma S.A. is part of the Healthcare sector.
Celon Pharma S.A. has a market cap of 871.62M PLN, based on the latest quote.
